PulseAugur
实时 22:27:32
English(EN) Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories

AI利用血液检测提前数年预测胰腺癌风险

研究人员开发了一种基于Transformer的神经网络,能够利用常规血液检测和临床病史数据提前数年预测胰腺癌风险。该模型在超过6000名胰腺癌患者和177,000名对照者的样本上进行训练,并在外部验证测试中展现出强大的预测准确性。该工具旨在实现人群级别的数字化富集,以实现早期检测和更广泛的治愈性治疗机会。 AI

影响 有望显著提高胰腺癌的早期检测率,从而实现更有效的治疗。

排序理由 该集群包含一篇详细介绍用于医学研究的新AI模型的学术论文。

在 arXiv cs.LG 阅读 →

AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →

AI利用血液检测提前数年预测胰腺癌风险

报道来源 [2]

  1. arXiv cs.LG TIER_1 English(EN) · Chris Varghese, Leo Y. Li-Han, Richa Bisht, Ellen Larson, Frank Lee, Ryan M. Carr, Tanios S. Bekaii-Saab, Shounak Majumder, John D. Halamka, Mark Truty, Ajit H. Goenka, Hojjat Salehinejad, Cornelius A. Thiels ·

    Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories

    arXiv:2605.30275v1 Announce Type: new Abstract: Earlier detection of pancreatic cancer is key to enabling wider access to curative treatment and reducing cancer deaths; however, screening is presently not viable. Latent indicators of pathology are evident in an individual's disea…

  2. arXiv cs.LG TIER_1 English(EN) · Cornelius A. Thiels ·

    Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories

    Earlier detection of pancreatic cancer is key to enabling wider access to curative treatment and reducing cancer deaths; however, screening is presently not viable. Latent indicators of pathology are evident in an individual's disease and blood test trajectories and may predict t…